Res. Asst. GÜLDEN PAÇACI ÇETİN

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye

Demir M., TUNAKAN DALGIÇ C., METE GÖKMEN E. N., SAVAŞ R., EROĞLU S., Ozden G., et al.

MEDICINA-LITHUANIA , vol.60, no.3, 2024 (SCI-Expanded)

Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled?

KARADOĞAN D., YILMAZEL UÇAR E., YAVUZ Y., BAÇÇIOĞLU A., Oeztuerk A. B., Bozkurt N., et al.

JOURNAL OF ASTHMA , vol.61, no.6, pp.539-549, 2024 (SCI-Expanded) Sustainable Development

Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma

PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.

JOURNAL OF ASTHMA , vol.61, no.1, pp.20-26, 2024 (SCI-Expanded)

The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma

ARSLAN B., PAÇACI ÇETİN G., YILMAZ İ.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY , vol.36, no.4, pp.189-209, 2023 (SCI-Expanded)

Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?

ARSLAN B., PAÇACI ÇETİN G., Turk M., GÜLMEZ İ., YILMAZ İ.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.10, pp.1071-1077, 2022 (SCI-Expanded)

Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT

PAÇACI ÇETİN G., YILMAZ İ., Turk M., ARSLAN B., Bahcecioglu S. N.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, pp.1223-1234, 2022 (SCI-Expanded)

A case of hypersensitivity developing against trace element solution in total parenteral nutrition, proved by skin prick test

PAÇACI ÇETİN G., Turk M., Bahcecioglu S. N., YILMAZ İ.

EUROPEAN JOURNAL OF CLINICAL NUTRITION , vol.75, no.12, pp.1829-1831, 2021 (SCI-Expanded)

The Visible and Invisible Faces of the Iceberg of Type 2 Asthma

YILMAZ İ., PAÇACI ÇETİN G.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , vol.203, no.11, pp.1443-1444, 2021 (SCI-Expanded)

Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma

YILMAZ İ., Nazik Bahcecioglu S., Turk M., TUTAR N., PAÇACI ÇETİN G., ARSLAN B.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1953-1959, 2021 (SCI-Expanded)

Articles Published in Other Journals

The definition of remission in asthma should be unique and specific

Yilmaz I., ÇETİN g., Türk M.

Tüberküloz ve Toraks , vol.72, no.2, pp.176-178, 2024 (ESCI)

Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study

TÜRK M., YILMAZ İ., Bahcecioglu S. N., PAÇACI ÇETİN G., Elieh-Ali-Komi D., Maurer M.

ASTHMA ALLERGY IMMUNOLOGY , vol.22, no.1, pp.49-57, 2024 (ESCI)

Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., PAÇACI ÇETİN G., Elieh-ali-komi D., Maurer M.

ASTHMA ALLERGY IMMUNOLOGY , 2023 (ESCI)

Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma

YILMAZ İ., ÇETİN G. P., ARSLAN B., ŞEKER S., YILMAZ H. E. B., AKTAŞ E., et al.

Tüberküloz ve Toraks , vol.71, no.1, pp.75-93, 2023 (ESCI)

Biologics for the treatment of severe asthma: Current status report 2023 Ağır astım tedavisinde biyolojikler: Güncel durum raporu 2023

PAÇACI ÇETİN G., Kepil Özdemir S., Can Bostan Ö., Öztop N., Çelebi Sözener Z., KARAKAYA G., et al.

Tuberkuloz ve Toraks , vol.71, no.2, pp.176-187, 2023 (ESCI)

Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study

NAZİK BAHÇECİOĞLU S., TURK M., ATAYIK E., PAÇACI ÇETİN G., ARSLAN B., GÜLMEZ İ., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2, pp.81-86, 2022 (ESCI)

Safety Profiles of Biological Therapies Used in Asthma Treatment

PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , vol.20, no.3, pp.127-141, 2022 (ESCI)

The adequacy of current diagnostic criteria for making a diagnosis of ABPA

Bahcecioglu S. N., Turk M., PAÇACI ÇETİN G., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.2, pp.141-148, 2022 (ESCI)

The Management of Acute and Chronic Urticaria

YILMAZ İ., PAÇACI ÇETİN G., ARSLAN B., Turk M.

ASTIM ALLERJI IMMUNOLOJI , vol.20, no.3, pp.202-204, 2022 (ESCI)

Long-term macrolide therapy in asthma

PAÇACI ÇETİN G., Arslan B., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.4, pp.520-534, 2021 (ESCI) Sustainable Development

Asthma phenotype and endotype definitions

YILMAZ İ., PAÇACI ÇETİN G.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.2, pp.288-290, 2021 (ESCI)

Blood hyperreosinophilia: A diagnostic challenge

PAÇACI ÇETİN G., KÖSE M., ARSLAN B., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3, pp.408-415, 2021 (ESCI)

Should There be a Washout Period When Switching to Another Biological in Asthma?

PAÇACI ÇETİN G., Yilmaz H. E. B., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , vol.17, no.1, pp.25-27, 2019 (ESCI)

Metrics

Publication

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citiation (TrDizin)

H-Index (TrDizin)

Project

Open Access

UN Sustainable Development Goals

Publications & Works